Polypharmakos Overview

  • Founded
  • 2016
  • Status
  • Private
  • Employees
  • 2
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $742K
Latest Deal Amount
  • Investors
  • 3

Polypharmakos General Information


Developer of antimicrobial actives designed to address the emerging global antimicrobial resistance crisis. The company's products are prepared from plants, fungi and other natural product sources, enabling pharmaceutical, consumer health and agritech sectors to have chemical-free drug treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Orchard Lea Horns Lane
  • Combe, Witney
  • Oxfordshire OX29 8NH
  • England, United Kingdom
+44 07831 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Polypharmakos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 30-Jan-2017 $742K 00000 00.000 Completed Generating Revenue
To view Polypharmakos’s complete valuation and funding history, request access »

Polypharmakos Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 00.000
To view Polypharmakos’s complete cap table history, request access »

Polypharmakos Executive Team (6)

Name Title Board Seat Contact Info
John Normanton Co-Founder, Chief Executive Officer & Board Member
Tom Sopwith Co-Founder, Chief Operating Officer, Operations & Board Member
Monique Simmonds Ph.D Co-Founder & Board Member
Clare Bryant Ph.D Co-Founder
Mark Holmes Ph.D Co-Founder
You’re viewing 5 of 6 executive team members. Get the full list »

Polypharmakos Board Members (3)

Name Representing Role Since
John Normanton Polypharmakos Co-Founder, Chief Executive Officer & Board Member 000 0000
Monique Simmonds Ph.D Polypharmakos Co-Founder & Board Member 000 0000
Tom Sopwith Polypharmakos Co-Founder, Chief Operating Officer, Operations & Board Member 000 0000
To view Polypharmakos’s complete board members history, request access »

Polypharmakos Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Polypharmakos Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cambridge Enterprise Angel Group Minority 000 0000 000000 0
Parkwalk Advisors Venture Capital Minority 000 0000 000000 0
Swansea Innovations Other Minority 000 0000 000000 0
To view Polypharmakos’s complete investors history, request access »